---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-085235"
form_type: "8-K"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2026-07-21T12:14:41+00:00"
generated_at: "2026-07-21T12:20:09.087651+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# VYNE announces 1-for-50 reverse stock split and $17.3M special dividend for Yarrow merger

## Summary
- Reverse stock split at 1-for-50 reduces outstanding shares from ~33.4M to ~0.7M.
- Aggregate special cash dividend of $17.3M ($0.40242/share) payable July 23 to holders of record July 22.
- Merger with Yarrow Bioscience expected to close July 24; combined company to trade as YARW on Nasdaq on July 27.
- Post-merger combined company shares: ~2.7M basic, ~33.6M fully diluted.
- Stockholders approved reverse split and increase in authorized shares from 150M to 300M at July 16 special meeting.

## SEC filing metadata
- accession: 0001104659-26-085235
- form_type: 8-K
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2026-07-21T12:14:41+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465926085235/0001104659-26-085235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465926085235/tm2620874d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-085235
- JSON: https://secwatch.observer/filing/0001104659-26-085235.json
- Plain text: https://secwatch.observer/filing/0001104659-26-085235.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.